Philip Insel
31 – 40 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
- Contribution to journal › Article
-
Mark
Amyloid pathology in the progression to mild cognitive impairment
- Contribution to journal › Article
- 2017
-
Mark
Cross-validation of optimized composites for preclinical Alzheimer's disease
(2017) In Alzheimer's and Dementia: Translational Research and Clinical Interventions 3(1). p.123-129
- Contribution to journal › Article
-
Mark
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
- Contribution to journal › Article
-
Mark
Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression
- Contribution to journal › Article
-
Mark
Serum tau and neurological outcome in cardiac arrest
- Contribution to journal › Article
-
Mark
Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition : Evidence for emerging amyloid pathology in alzheimer's disease
- Contribution to journal › Article
- 2016
-
Mark
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
- Contribution to journal › Article
-
Mark
Plasma tau in Alzheimer disease
- Contribution to journal › Article
